Results 1 to 10 of about 1,793,959 (342)
Acknowledgment to the Reviewers of Advances in Respiratory Medicine in 2022 [PDF]
High-quality academic publishing is built on rigorous peer review [...]
Advance in Respiratory Medicine Editorial Office
doaj +2 more sources
Background: This study used a mixed-methods design, analyzing quantitative pre- and post-assessment scores alongside qualitative student feedback. Undergraduate students in Respiratory Medicine were randomly assigned to either the Flipped Classroom or ...
Ramesh Pandey +5 more
doaj +2 more sources
The American Thoracic Society Research Program: Twenty Years of Driving Discovery in Respiratory Medicine. [PDF]
Atabai K +7 more
europepmc +3 more sources
The Cough Reflex: The Janus of Respiratory Medicine. [PDF]
Sykes DL, Morice AH.
europepmc +3 more sources
International tourist arrivals continue to increase over time due to global economic growth, increasing middle class in developing countries, technological advances, innovative business concepts, cost-effective travel, and facilitation of visas.
Ni Wayan Candrawati
doaj +1 more source
This report described a rare case of subcutaneous anaerobic bacterial abscess due to Peptoniphilus olsenii and Gleimia europaea after COVID‐19. The patient received incision and drainage of the abscess and antibiotics, thereby achieving recovery ...
Yuji Yamamoto +9 more
doaj +1 more source
Background and Aim The efficacy of Sequential Organ Failure Assessment (SOFA) score as predictor of clinical outcomes among ICU‐admitted COVID‐19 patients is still controversial.
Farzad Esmaeili Tarki +5 more
doaj +1 more source
Primary intrapulmonary thymoma a case report
Primary intrapulmonary thymoma (PIT), defined as the presence of thymoma tissue in the lung without an accompanying mediastinal component, is uncommon and so offers a diagnostic quandary. We describe the case of PIT in an 81‐year‐old man.
Sheikh Muhammad Wasim Jamal +8 more
doaj +1 more source
Omalizumab for the treatment of severe allergic asthma in children: A tale of two
Omalizumab is a monoclonal antibody which targets immunoglobulin E. It is approved as an add‐on therapy for children with severe allergic asthma. Assessment of endotype and phenotype is necessary in order to correctly identify those patients who are most
Sinéad Brannick +4 more
doaj +1 more source
Elexacaftor/tezacaftor/ivacaftor (ETI) is a cystic fibrosis (CF) transmembrane regulator (CFTR) modulator. It is known to be efficacious in stable patients with severe pneumopathy, but there are few data concerning its effectiveness during acute ...
Donatello Salvatore +4 more
doaj +1 more source

